Oculis Holding AG
NASDAQ:OCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
East Money Information Co Ltd
SZSE:300059
|
CN |
|
T
|
Titagarh Rail Systems Ltd
NSE:TITAGARH
|
IN |
Oculis Holding AG
Intangible Assets
Oculis Holding AG
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Oculis Holding AG
NASDAQ:OCS
|
Intangible Assets
CHf13.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Novartis AG
SIX:NOVN
|
Intangible Assets
$29.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Intangible Assets
CHf19.3B
|
CAGR 3-Years
26%
|
CAGR 5-Years
10%
|
CAGR 10-Years
3%
|
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Intangible Assets
$1.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Oculis Holding AG
Glance View
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improve eye care. The company is headquartered in Zug, Zug and currently employs 28 full-time employees. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
See Also
What is Oculis Holding AG's Intangible Assets?
Intangible Assets
13.3m
CHF
Based on the financial report for Dec 31, 2025, Oculis Holding AG's Intangible Assets amounts to 13.3m CHF.
What is Oculis Holding AG's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
9%
Over the last year, the Intangible Assets growth was 0%. The average annual Intangible Assets growth rates for Oculis Holding AG have been 3% over the past three years , 9% over the past five years .
